At a plant nestled along a highway 20 miles north of Boston, hundreds of Pfizer Inc. workers are gearing up to produce millions of doses of a new vaccine that
Updated: 10:57 PM EDT Apr 14, 2021 Moderna executives are sharing what they believe are the next steps needed to bring an end to the COVID-19 pandemic.During a presentation to investors on Wednesday, leaders of the Cambridge-based company outlined a strategy to battle COVID-19 variants, as they think the coronavirus will not be going away anytime soon. What we expect to have happen over the coming one to two years is a series of variant driven epidemics . until we re able to protect the majority of humans and achieve something akin to herd immunity, said Dr. Stephen Hoge, president of Moderna.Hoge and other Moderna executives say they believe COVID-19 could be a more seasonal virus, much like other respiratory viruses, in about two years.
COVID Vaccine Makers to Congress: Expect Steady Rise in US Supply medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
"We've been in the process of developing a manufacturing process for a vaccine product that we've never made before," Pfizer Chief Business Officer John Young said.